Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

A simple to implement and low-cost supervised walking programme in highly motivated individuals with or at risk for type 2 diabetes: An observational study with a pre-post design.

Hoogendoorn SW, Rutten GEHM, Hart HE, de Wolf C, Vos RC.

Prev Med Rep. 2018 Nov 7;13:30-36. doi: 10.1016/j.pmedr.2018.11.003. eCollection 2019 Mar.

2.

Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy.

DE Wolf C, VAN DE Bovenkamp M, Hoefnagel M.

Cytotherapy. 2018 Nov;20(11):1289-1308. doi: 10.1016/j.jcyt.2018.07.006. Epub 2018 Oct 14. Review.

PMID:
30327247
3.

Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy.

de Wolf C, van de Bovenkamp M, Hoefnagel M.

Cytotherapy. 2018 May;20(5):601-622. doi: 10.1016/j.jcyt.2018.01.011. Epub 2018 Mar 26. Review.

PMID:
29598903
4.

ABT-737 and pictilisib synergistically enhance pitavastatin-induced apoptosis in ovarian cancer cells.

De Wolf E, De Wolf C, Richardson A.

Oncol Lett. 2018 Feb;15(2):1979-1984. doi: 10.3892/ol.2017.7516. Epub 2017 Dec 5.

5.

A Machine Learning Approach to Automated Gait Analysis for the Noldus Catwalk System.

Frohlich H, Claes K, De Wolf C, Van Damme X, Michel A.

IEEE Trans Biomed Eng. 2018 May;65(5):1133-1139. doi: 10.1109/TBME.2017.2701204. Epub 2017 Aug 24.

PMID:
28858780
6.

Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy.

de Wolf C, van de Bovenkamp M, Hoefnagel M.

Cytotherapy. 2017 Jul;19(7):784-797. doi: 10.1016/j.jcyt.2017.03.076. Epub 2017 Apr 27. Review.

PMID:
28457740
7.

An Arthritis-Suppressive and Treg Cell-Inducing CD4+ T Cell Epitope Is Functional in the Context of HLA-Restricted T Cell Responses.

de Wolf C, van der Zee R, den Braber I, Glant T, Maillère B, Favry E, van Lummel M, Koning F, Hoek A, Ludwig I, van Eden W, Broere F.

Arthritis Rheumatol. 2016 Mar;68(3):639-47. doi: 10.1002/art.39444.

8.

Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs.

Michel A, Downey P, Van Damme X, De Wolf C, Schwarting R, Scheller D.

PLoS One. 2015 Aug 31;10(8):e0135949. doi: 10.1371/journal.pone.0135949. eCollection 2015.

9.

Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity.

McCutcheon S, Langeveld JP, Tan BC, Gill AC, de Wolf C, Martin S, Gonzalez L, Alibhai J, Blanco AR, Campbell L, Hunter N, Houston EF.

PLoS One. 2014 Mar 7;9(3):e91143. doi: 10.1371/journal.pone.0091143. eCollection 2014.

10.

Mammographic screening programmes in Europe: organization, coverage and participation.

Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, Hofvind S, Nyström L, Segnan N, Ponti A; Eunice Working Group, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:72-82.

PMID:
22972813
11.

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:57-66. Review.

PMID:
22972811
12.

Significant differences in incubation times in sheep infected with bovine spongiform encephalopathy result from variation at codon 141 in the PRNP gene.

Tan BC, Blanco AR, Houston EF, Stewart P, Goldmann W, Gill AC, de Wolf C, Manson JC, McCutcheon S.

J Gen Virol. 2012 Dec;93(Pt 12):2749-56. doi: 10.1099/vir.0.039008-0. Epub 2012 Sep 12.

PMID:
22971821
13.

E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1.

Weijts BG, Bakker WJ, Cornelissen PW, Liang KH, Schaftenaar FH, Westendorp B, de Wolf CA, Paciejewska M, Scheele CL, Kent L, Leone G, Schulte-Merker S, de Bruin A.

EMBO J. 2012 Oct 3;31(19):3871-84. doi: 10.1038/emboj.2012.231. Epub 2012 Aug 17.

14.

Effect of population-based screening on breast cancer mortality.

Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, den Heeten A, Doyle G, Fox R, Frigerio A, Gilbert F, Hecht G, Heindel W, Heywang-Köbrunner SH, Holland R, Jones F, Lernevall A, Madai S, Mairs A, Muller J, Nisbet P, O'Doherty A, Patnick J, Perry N, Regitz-Jedermann L, Rickard M, Rodrigues V, Del Turco MR, Scharpantgen A, Schwartz W, Seradour B, Skaane P, Tabar L, Tornberg S, Ursin G, Van Limbergen E, Vandenbroucke A, Warren LJ, Warwick L, Yaffe M, Zappa M.

Lancet. 2011 Nov 19;378(9805):1775-6. doi: 10.1016/S0140-6736(11)61766-2. No abstract available. Erratum in: Lancet. 2013 Feb 16;381(9866):536.

PMID:
22098846
15.

All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD.

McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, Smith A, Groschup MH, Hunter N, Hornsey VS, MacGregor IR, Prowse CV, Turner M, Manson JC.

PLoS One. 2011;6(8):e23169. doi: 10.1371/journal.pone.0023169. Epub 2011 Aug 17.

16.

How effective are breast cancer screening programmes by mammography? Review of the current evidence.

Schopper D, de Wolf C.

Eur J Cancer. 2009 Jul;45(11):1916-23. doi: 10.1016/j.ejca.2009.03.022. Epub 2009 Apr 22. Review.

PMID:
19398327
17.

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.

de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ.

Eur J Cancer. 2009 Jan;45(1):127-38. doi: 10.1016/j.ejca.2008.09.015. Epub 2008 Nov 27.

PMID:
19038540
18.

Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.

de Wolf C, Jansen R, Yamaguchi H, de Haas M, van de Wetering K, Wijnholds J, Beijnen J, Borst P.

Mol Cancer Ther. 2008 Sep;7(9):3092-102. doi: 10.1158/1535-7163.MCT-08-0427. Epub 2008 Sep 2.

19.

European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.

Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L.

Ann Oncol. 2008 Apr;19(4):614-22. Epub 2007 Nov 17. Review.

PMID:
18024988
21.

Suitability of instant noodles for iron fortification to combat iron-deficiency anemia among primary schoolchildren in rural Vietnam.

Le HT, Brouwer ID, de Wolf CA, van der Heijden L, Nguyen KC, Kok FJ.

Food Nutr Bull. 2007 Sep;28(3):291-8.

PMID:
17974362
22.

Efficacy of iron-fortified whole maize flour on iron status of schoolchildren in Kenya: a randomised controlled trial.

Andang'o PE, Osendarp SJ, Ayah R, West CE, Mwaniki DL, De Wolf CA, Kraaijenhagen R, Kok FJ, Verhoef H.

Lancet. 2007 May 26;369(9575):1799-1806. doi: 10.1016/S0140-6736(07)60817-4.

PMID:
17531887
23.

Guidelines on the standards for the training of specialised health professionals dealing with breast cancer.

Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, Redmond K, Rosselli Del Turco M, Rijken H, Kearney N, Ellis IO, Di Leo A, Orecchia R, Noel A, Andersson M, Audretsch W, Bjurstam N, Blamey RW, Blichert-Toft M, Bosmans H, Burch A, Bussolati G, Christiaens MR, Colleoni M, Cserni G, Cufer T, Cush S, Damilakis J, Drijkoningen M, Ellis P, Foubert J, Gambaccini M, Gentile E, Guedea F, Hendriks J, Jakesz R, Jassem J, Jereczek-Fossa BA, Laird O, Lartigau E, Mattheiem W, O'higgins N, Pennery E, Rainsbury D, Rutgers E, Smola M, Van Limbergen E, von Smitten K, Wells C, Wilson R; EUSOMA.

Eur J Cancer. 2007 Mar;43(4):660-75. Epub 2007 Feb 5.

PMID:
17276672
24.

cGMP transport by vesicles from human and mouse erythrocytes.

de Wolf CJ, Yamaguchi H, van der Heijden I, Wielinga PR, Hundscheid SL, Ono N, Scheffer GL, de Haas M, Schuetz JD, Wijnholds J, Borst P.

FEBS J. 2007 Jan;274(2):439-50.

25.

The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models.

Breedveld P, Pluim D, Cipriani G, Dahlhaus F, van Eijndhoven MA, de Wolf CJ, Kuil A, Beijnen JH, Scheffer GL, Jansen G, Borst P, Schellens JH.

Mol Pharmacol. 2007 Jan;71(1):240-9. Epub 2006 Oct 10.

PMID:
17032904
26.

Interleukin-6 induction of protein s is regulated through signal transducer and activator of transcription 3.

de Wolf CJ, Cupers RM, Bertina RM, Vos HL.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2168-74. Epub 2006 Jul 13.

PMID:
16840717
27.
28.

Multidrug resistance-associated proteins 3, 4, and 5.

Borst P, de Wolf C, van de Wetering K.

Pflugers Arch. 2007 Feb;453(5):661-73. Epub 2006 Apr 4. Review.

PMID:
16586096
29.

Initiation of Protein S mRNA synthesis in human liver and various cell lines.

De Wolf CJ, Cupers RM, Bertina RM, Vos HL.

J Thromb Haemost. 2005 Feb;3(2):410-2. No abstract available. Erratum in: J Thromb Haemost. 2005 Mar;3(3):622.

30.

Zinc finger proteins act as transcriptional repressors of alkaloid biosynthesis genes in Catharanthus roseus.

Pauw B, Hilliou FA, Martin VS, Chatel G, de Wolf CJ, Champion A, Pré M, van Duijn B, Kijne JW, van der Fits L, Memelink J.

J Biol Chem. 2004 Dec 17;279(51):52940-8. Epub 2004 Oct 1.

31.

Management of women with ductal carcinoma in situ of the breast: a population-based study.

Verkooijen HM, Fioretta G, De Wolf C, Vlastos G, Kurtz J, Borisch B, Schäfer P, Spiliopoulos A, Sappino AP, Renella R, Pittet B, Schmid De Gruneck J, Wespi Y, Neyroud-Caspar I, Bouchardy C.

Ann Oncol. 2002 Aug;13(8):1236-45.

PMID:
12181247
32.

Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes.

Notley LM, De Wolf CJ, Wunsch RM, Lancaster RG, Gillam EM.

Chem Res Toxicol. 2002 May;15(5):614-22.

PMID:
12018981
33.

Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.

Bouchardy C, Queneau PE, Fioretta G, Usel M, Zellweger M, Neyroud I, Raymond L, de Wolf C, Sappino AP.

Br J Cancer. 2001 Nov 2;85(9):1251-7.

34.

ESGO consensus document on cervical cancer screening. European Society of Gynaecological Oncology.

Patnick J, Monsonego J, de Wolf C, Verbeek A, Bonte J, Agnantis N, De Oliveira CF, Dexeus S, Maggino T, Onnis A, Zielinski J.

Eur J Gynaecol Oncol. 2001;22(2):99-101. Review. No abstract available.

PMID:
11446489
35.
36.

European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group.

O'Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wolf C, Rochard F, Rutgers EJ, Roberts PJ, Mattheiem W, da Silva MA, Holmberg L, Schulz KD, Smola MG, Mansel RE.

Ann Chir Gynaecol. 1998;87(1):110-2.

PMID:
9598249
37.

European guidelines for quality assurance in the surgical management of mammographically detected lesions.

O'Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wolf C, Rochard F, Rutgers EJ, Roberts P, Mattheiem W, da Silva MA, Holmberg L, Schulz KD, Smola MG, Mansel RE.

Eur J Surg Oncol. 1998 Apr;24(2):96-8. Review. No abstract available.

PMID:
9591022
38.

[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].

Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Böcker W, Bussolati G, Connolly CE, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Holland R, Jacquemier J, Lacerda M, Lindgren A, Martinez-Peñuela J, Peterse JL, Rank F, Tsakraklides V, de Wolf C, Zafrani B.

Pathologe. 1997 Jan;18(1):71-88. German. No abstract available.

PMID:
9157408
39.

Structural Aspects of Lithium Arenethiolate Complexes with Intramolecular Coordinating Amine Donors.

Janssen MD, Rijnberg E, de Wolf CA, Hogerheide MP, Kruis D, Kooijman H, Spek AL, Grove DM, van Koten G.

Inorg Chem. 1996 Nov 6;35(23):6735-6741.

PMID:
11666836
40.

New developments in cervical cancer screening and prevention. Geneva, Switzerland, June 17-19 1996. Workshop.

Franco E, Syrjänen K, de Wolf C, Patnick J, Ferenczy A, McGoogan E, Bosch X, Singer A, Muñoz N, Meheus A, Monsonego J.

Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):853-6. No abstract available.

41.

Breast cancer screening in the framework of the Europe against Cancer programme.

de Waard F, Kirkpatrick A, Perry NM, Tornberg S, Tubiana M, de Wolf C.

Eur J Cancer Prev. 1994 Jan;3 Suppl 1:3-5. No abstract available.

PMID:
8130724
42.

Lymphoid and non-lymphoid cells in the adenoid of children with otitis media with effusion: a comparative study.

van Nieuwkerk EB, de Wolf CJ, Kamperdijk EW, van der Baan S.

Clin Exp Immunol. 1990 Feb;79(2):233-9.

Supplemental Content

Loading ...
Support Center